Feb. 6, 2026
Jury awards Applied Medical $381M in antitrust trial against Medtronic
Los Angeles jurors concluded Medtronic used bundled hospital contracts to maintain a monopoly over advanced bipolar energy devices, delivering a $381.7 million verdict to rival Applied Medical.
A Los Angeles jury awarded more than $381 million to Applied Medical Resources Corp. in a high-stakes federal antitrust trial accusing Medtronic of monopolistic contracting practices involving surgical devices.
The jury unanimously found that Medtronic violated the Sherman Act for monopolization, attempted monopolization, and unreasonable restraint of trade, and the Clayton Act for unlawful exclusive dealing and the California Cartwright Act, awarding the plaintiff $381,705,005. <...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In